"On October 9, 2025, the IRS issued Rev. Proc. 2025-32, which announces the 2026 indexed limits for certain health and welfare benefits. This is in addition to the limits the IRS announced in Rev. Proc. 2025-19 on May 1, 2025." [A chart shows 2025 and 2026 limits.]  MORE >>

"The agreement [1] will provide every State Medicaid program in the country access to MFN drug prices on AstraZeneca products.... [2] guarantee[s] MFN prices on all new innovative medicines AstraZeneca brings to market.... [3] requires AstraZeneca to repatriate increased foreign revenue on existing products ... [4] requires AstraZeneca to offer medicines at a deep discount off the list price when selling directly to American patients."  MORE >>

"Healthcare costs are rising, and traditional group plans no longer fit today's distributed workforce. This blog breaks down what an Individual Coverage Health Reimbursement Arrangement (ICHRA) is, how it works, and the key differences between ICHRAs and QSEHRAs.... [It] explores the pros and cons of this modern benefits model and how it helps employers control costs while giving employees real choice."  MORE >>

"Employer-sponsored health insurance (ESI) is the largest source of health coverage for non-elderly U.S. residents. ... Providing health insurance through workplaces is an efficient way of offering coverage options to working families, and the tax benefits of employer-based coverage further enhance its attractiveness. Yet, ESI often results in uneven coverage, especially for those with low wages or those working at smaller firms. "  MORE >>

"Employer sponsored health insurance plans are about to see the biggest increases in cost in 15 years ... The cost spike has become a 'call to action,' prompting 59% of employers to implement cost-cutting measures for 2026, up from 48% last year. Here's why prices are expected to increase, how employers and employees are responding, and how to prepare for a pricier year."  MORE >>

"We can't just pay hospitals more for the same level of quality and care. We need to pay them to achieve better results.... Drug makers can price their products with no regulation, and enjoy patent protections that keep lower-cost competitors out of the market....[We] need to reform this system that drives drug prices -- and health insurance premiums -- higher."  MORE >>

"Lawyers representing patients in a lawsuit against United Behavioral Health for insufficient mental health and substance abuse treatment coverage may face a tentative $50,000 sanction for disclosing confidential information to the [DOL].... The court ruled that the lawyers violated [a] protective order by engaging in a collective interest agreement, through which it transmitted documents to the DOL." [L.D. v. United Behavioral Health, No. 20-2254 (N.D. Calif. Oct. 7, 2025)]  MORE >>